BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff
18 Feb, 2016, 08:30 ET
FREDERICK, Md., Feb. 18, 2016 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that B. Braun has initiated the application for a listing of RecoveryRx® on the National Health Service (NHS) drug tariff (http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx). The UK drug tariff list establishes payment for prescription costs in the UK.
"Orthopedic surgeons who are using RecoveryRx see a significant clinical benefit," commented Phil Cleary, Senior Product Group Manager, B. Braun Medical Ltd. "Obtaining a listing on the drug tariff will facilitate greater inclusion of RecoveryRx in all aspects of postoperative and rehabilitation care in orthopedics."
"We are optimistic with the clinical data now available that RecoveryRx will be added to the drug tariff thereby its costs to patients will be covered by the NHS," said Ian Rawe, Ph. D., Director of Research, BioElectronics. "A successful listing of RecoveryRx should enable ActiPatch® to be also added to the drug tariff and help to further increase sales of these innovative pain therapy devices in the UK."
About B. Braun Medical Ltd
B. Braun Medical Ltd is the UK member of the B. Braun Group, one of the world's leading healthcare companies. B. Braun manufactures and distributes on a global basis, employing more than 50,000 people worldwide. B. Braun offers healthcare professionals and hospitals an outstanding range of products, from surgical instruments, innovative implants, and therapeutic systems. For more information, please visit www.bbraun.co.uk.
About BioElectronics Corporation
BioElectronics Corporation is a leader in bioelectroceutical devices and the maker of an industry leading family of disposable, drug-free, anti-inflammatory devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy for veterinary applications, Allay® Menstrual Pain Therapy and Smart Insole™ Heel Pain Therapy. Visit www.bielcorp.com for more information.
SOURCE BioElectronics Corporation
Share this article